Open Beta
TREN
MetriLume
TREN

US marketsADMA

SEC-sourced researchBeta

ADMA

ADMA BIOLOGICS, INC.

Company comparison ↗

Data passport

CIK
0001368514
Exchange
Nasdaq
Business activity
Biological Products, (No Diagnostic Substances) · SIC 2836
Financial inputs
6/6
Filing date
Aug 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 258,215,000.0000 USD; December 2024: 426,454,000.0000 USD; December 2025: 510,173,000.0000 USD510.2M USD0 USD0December 2023December 2024December 2025
ADMA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023258,215,000.0000Feb 25, 2026
December 2024426,454,000.0000Feb 25, 2026
December 2025510,173,000.0000Feb 25, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025510,173,000.0000146,930,000.000050,396,000.0000624,242,000.0000146,922,000.0000Feb 25, 2026
December 2024426,454,000.0000197,673,000.0000118,672,000.0000488,678,000.0000139,660,000.0000Feb 25, 2026
December 2023258,215,000.0000-28,239,000.00008,800,000.0000329,182,000.0000—Feb 25, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

83/100
Profitability100
Growth70
Balance sheet76
Cash generation70
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$510.17MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$426.45MJan 1, 2024 – Dec 31, 2024Feb 25, 202610-K
Net incomeNetIncomeLoss$146.93MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$50.4MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Total assetsAssets$624.24MDec 31, 2025Feb 25, 202610-K
Total liabilitiesLiabilities$146.92MDec 31, 2025Feb 25, 202610-K

New filings

Explore methodology ↗